Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations
File(s)1-s2.0-S0091674914001882-main.pdf (2.48 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Background
The fungal allergen Alternaria alternata is implicated in severe asthma and rapid onset life-threatening exacerbations of disease. However, the mechanisms that underlie this severe pathogenicity remain unclear.
Objective
We sought to investigate the mechanism whereby Alternaria was capable of initiating severe, rapid onset allergic inflammation.
Methods
IL-33 levels were quantified in wild-type and ST2−/− mice that lacked the IL-33 receptor given inhaled house dust mite, cat dander, or Alternaria, and the effect of inhibiting allergen-specific protease activities on IL-33 levels was assessed. An exacerbation model of allergic airway disease was established whereby mice were sensitized with house dust mite before subsequently being challenged with Alternaria (with or without serine protease activity), and inflammation, remodeling, and lung function assessed 24 hours later.
Results
Alternaria, but not other common aeroallergens, possessed intrinsic serine protease activity that elicited the rapid release of IL-33 into the airways of mice through a mechanism that was dependent upon the activation of protease activated receptor-2 and adenosine triphosphate signaling. The unique capacity of Alternaria to drive this early IL-33 release resulted in a greater pulmonary inflammation by 24 hours after challenge relative to the common aeroallergen house dust mite. Furthermore, this Alternaria serine protease–IL-33 axis triggered a rapid, augmented inflammation, mucus release, and loss of lung function in our exacerbation model.
The fungal allergen Alternaria alternata is implicated in severe asthma and rapid onset life-threatening exacerbations of disease. However, the mechanisms that underlie this severe pathogenicity remain unclear.
Objective
We sought to investigate the mechanism whereby Alternaria was capable of initiating severe, rapid onset allergic inflammation.
Methods
IL-33 levels were quantified in wild-type and ST2−/− mice that lacked the IL-33 receptor given inhaled house dust mite, cat dander, or Alternaria, and the effect of inhibiting allergen-specific protease activities on IL-33 levels was assessed. An exacerbation model of allergic airway disease was established whereby mice were sensitized with house dust mite before subsequently being challenged with Alternaria (with or without serine protease activity), and inflammation, remodeling, and lung function assessed 24 hours later.
Results
Alternaria, but not other common aeroallergens, possessed intrinsic serine protease activity that elicited the rapid release of IL-33 into the airways of mice through a mechanism that was dependent upon the activation of protease activated receptor-2 and adenosine triphosphate signaling. The unique capacity of Alternaria to drive this early IL-33 release resulted in a greater pulmonary inflammation by 24 hours after challenge relative to the common aeroallergen house dust mite. Furthermore, this Alternaria serine protease–IL-33 axis triggered a rapid, augmented inflammation, mucus release, and loss of lung function in our exacerbation model.
Date Issued
2014-09-01
Date Acceptance
2014-02-03
Citation
Journal of Allergy and Clinical Immunology, 2014, 134 (3), pp.583-592.e6
ISSN
1097-6825
Publisher
Elsevier
Start Page
583
End Page
592.e6
Journal / Book Title
Journal of Allergy and Clinical Immunology
Volume
134
Issue
3
Copyright Statement
© 2014 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
License URL
Sponsor
Medical Research Council (MRC)
Medical Research Council (MRC)
Wellcome Trust
Wellcome Trust
Grant Number
G1000758
G1000758
087618/Z/08/Z
095707/Z/11/Z
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Immunology
Alternaria alternata
allergic airway disease
asthma exacerbation
protease
IL-33
IL-1-LIKE CYTOKINE IL-33
FUNGAL SPORES
INHALED CORTICOSTEROIDS
ALLERGIC INFLAMMATION
AIRWAY INFLAMMATION
IMMUNE-RESPONSES
RISK-FACTOR
MAST-CELL
RECEPTOR
SEVERITY
Publication Status
Published
Date Publish Online
2014-03-15